HARBOR INVESTMENT ADVISORY, LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 145 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
HARBOR INVESTMENT ADVISORY, LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$7,682
+8.6%
5720.0%0.00%0.0%
Q4 2022$7,076
-11.6%
5720.0%0.00%0.0%
Q3 2022$8,0000.0%5720.0%0.00%0.0%
Q2 2022$8,000
-11.1%
5720.0%0.00%0.0%
Q1 2022$9,0000.0%5720.0%0.00%0.0%
Q4 2021$9,000
+12.5%
5720.0%0.00%0.0%
Q3 2021$8,000
-27.3%
5720.0%0.00%0.0%
Q2 2021$11,000
-15.4%
5720.0%0.00%
-50.0%
Q1 2021$13,000
-7.1%
5720.0%0.00%0.0%
Q4 2020$14,000
-12.5%
572
+45.5%
0.00%
-33.3%
Q3 2020$16,000
+77.8%
393
+98.5%
0.00%
+50.0%
Q2 2020$9,000
-25.0%
1980.0%0.00%
-33.3%
Q1 2020$12,0001980.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders